Piramal Pharma Announces Completion of 20% Strategic Growth Investment by Carlyle

     
• Piramal Enterprises Limited completes the integration of its pharma businesses into its subsidiary - Piramal Pharma Limited

PEL raises funds of ~INR 14,500 Crores in FY2020

• INR 1,750 Crores from CDPQ against preferential allotment of CCDs


• INR 3,650 Crores from the Rights Issue | Over-subscribed ~1.14 times


• INR 6,750 Crores from the sale of Decision Resources Group


• INR 2,300 Crores from the stake sale in Shriram Transport Finance

Built on the foundation of Trusteeship, Piramal Group imbibes a business ethos that believes in creating value for all its stakeholders.

Mr. Ajay Piramal Chairman, Piramal Group

Committed to its corporate philosophy of ‘Doing Well and Doing Good’, Piramal Group is focused on building innovative solutions that positively impact the larger community.

Dr. Swati Piramal Vice Chairperson, Piramal Group

Delighted to partner with NITI Aayog and launch “Surakshit Dada Dadi Nana Nani Abhiyaan” in 112 Aspirational Districts across India